STOCK TITAN

[144] Twist Bioscience Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice from Twist Bioscience (TWST) shows an insider sale filing for common stock. The filer plans to sell 238 shares via Fidelity Brokerage Services on NASDAQ with an aggregate market value of $6,179.48 and an approximate sale date of 08/21/2025. The shares were acquired on 08/20/2025 through restricted stock vesting and were received as compensation. The filing lists four prior small common-stock sales by Robert Werner totaling 1,492 shares between 05/21/2025 and 08/04/2025 with gross proceeds reported for each sale. The notice includes the standard certification that the signer is unaware of undisclosed material adverse information.

Avviso Form 144 da Twist Bioscience (TWST) indica una comunicazione di vendita da parte di un insider per azioni ordinarie. Il dichiarante intende vendere 238 azioni tramite Fidelity Brokerage Services sul NASDAQ, con un valore di mercato complessivo di $6.179,48 e una data di vendita approssimativa del 21/08/2025. Le azioni sono state acquisite il 20/08/2025 mediante il vesting di azioni ristrette e ricevute come compenso. La comunicazione riporta inoltre quattro precedenti piccole vendite di azioni ordinarie da parte di Robert Werner per un totale di 1.492 azioni tra il 21/05/2025 e il 04/08/2025, con i proventi lordi indicati per ciascuna vendita. L’avviso include la certificazione standard che il firmatario non è a conoscenza di informazioni materiali avverse non divulgate.

Aviso Formulario 144 de Twist Bioscience (TWST) muestra una presentación de venta por parte de un insider de acciones ordinarias. El declarante planea vender 238 acciones a través de Fidelity Brokerage Services en NASDAQ, con un valor de mercado agregado de $6,179.48 y una fecha de venta aproximada del 21/08/2025. Las acciones se adquirieron el 20/08/2025 por consolidación de acciones restringidas y fueron recibidas como compensación. La presentación enumera además cuatro pequeñas ventas anteriores de acciones ordinarias por parte de Robert Werner por un total de 1,492 acciones entre el 21/05/2025 y el 04/08/2025, con los ingresos brutos informados para cada venta. El aviso incluye la certificación estándar de que el firmante no conoce información adversa material no divulgada.

Twist Bioscience(TWST)의 Form 144 통지는 내부자가 보통주를 매도하는 신고서를 나타냅니다. 신고인은 NASDAQ에서 Fidelity Brokerage Services를 통해 238주를 매도할 예정이며, 총 시가 가치는 $6,179.48이고 대략적인 매도 예정일은 2025-08-21입니다. 해당 주식은 2025-08-20에 제한주(리스트릭티드 스톡) 베스팅을 통해 보상으로 취득되었습니다. 신고서에는 또한 Robert Werner가 2025-05-21부터 2025-08-04 사이에 총 1,492주를 소액으로 매도한 네 건의 이전 거래가 기재되어 있으며, 각 거래의 총수익이 보고되어 있습니다. 통지에는 서명자가 공개되지 않은 중요한 불리한 정보를 알고 있지 않다는 표준 확인 문구가 포함되어 있습니다.

Avis Formulaire 144 de Twist Bioscience (TWST) indique un dépôt de vente par un initié concernant des actions ordinaires. Le déclarant prévoit de vendre 238 actions via Fidelity Brokerage Services sur le NASDAQ, pour une valeur de marché totale de 6 179,48 $ et une date de vente approximative au 21/08/2025. Les actions ont été acquises le 20/08/2025 lors de la levée de restrictions d'actions restreintes et ont été reçues en tant que rémunération. Le dépôt mentionne également quatre petites ventes antérieures d'actions ordinaires par Robert Werner totalisant 1 492 actions entre le 21/05/2025 et le 04/08/2025, avec les produits bruts indiqués pour chaque vente. L'avis inclut la certification standard selon laquelle le signataire n'est pas au courant d'informations défavorables importantes non divulguées.

Form 144-Mitteilung von Twist Bioscience (TWST) weist auf eine Insider-Verkaufsanzeige für Stammaktien hin. Der Einreicher plant, 238 Aktien über Fidelity Brokerage Services an der NASDAQ zu verkaufen, mit einem Gesamtmarktwert von $6.179,48 und einem ungefähr geplanten Verkaufsdatum am 21.08.2025. Die Aktien wurden am 20.08.2025 durch Vesting von eingeschränkten Aktien erworben und als Vergütung erhalten. Die Meldung listet außerdem vier frühere kleinere Verkäufe von Stammaktien durch Robert Werner mit insgesamt 1.492 Aktien zwischen dem 21.05.2025 und dem 04.08.2025 auf, wobei die Bruttoerlöse für jeden Verkauf angegeben sind. Die Mitteilung enthält die übliche Bestätigung, dass der Unterzeichner keine nicht offengelegten, wesentlichen nachteiligen Informationen kennt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small, routine insider sale from recently vested restricted stock; no material red flags in the filing.

The filing documents a proposed sale of 238 shares valued at $6,179.48 by an insider through Fidelity on NASDAQ, with acquisition dated 08/20/2025 via restricted stock vesting and payment characterized as compensation. Historical disposals by the same person total 1,492 shares across four trades earlier in 2025, with gross proceeds reported per trade. The sizes and timing suggest routine monetization of vested compensation rather than large-scale divestiture. The filing contains the standard attestation regarding knowledge of material nonpublic information.

TL;DR: Disclosure is complete for Rule 144 purposes; documentation shows compensation-related vesting followed by planned sales.

The Form 144 provides required elements: number of shares, acquisition date and nature (restricted stock vesting), broker details, planned sale date, and prior sales in the past three months. All listed transactions are relatively small in absolute terms and tied to compensation. The signature/attestation language is present. The filing does not disclose any material adverse facts or trading-plan adoption dates.

Avviso Form 144 da Twist Bioscience (TWST) indica una comunicazione di vendita da parte di un insider per azioni ordinarie. Il dichiarante intende vendere 238 azioni tramite Fidelity Brokerage Services sul NASDAQ, con un valore di mercato complessivo di $6.179,48 e una data di vendita approssimativa del 21/08/2025. Le azioni sono state acquisite il 20/08/2025 mediante il vesting di azioni ristrette e ricevute come compenso. La comunicazione riporta inoltre quattro precedenti piccole vendite di azioni ordinarie da parte di Robert Werner per un totale di 1.492 azioni tra il 21/05/2025 e il 04/08/2025, con i proventi lordi indicati per ciascuna vendita. L’avviso include la certificazione standard che il firmatario non è a conoscenza di informazioni materiali avverse non divulgate.

Aviso Formulario 144 de Twist Bioscience (TWST) muestra una presentación de venta por parte de un insider de acciones ordinarias. El declarante planea vender 238 acciones a través de Fidelity Brokerage Services en NASDAQ, con un valor de mercado agregado de $6,179.48 y una fecha de venta aproximada del 21/08/2025. Las acciones se adquirieron el 20/08/2025 por consolidación de acciones restringidas y fueron recibidas como compensación. La presentación enumera además cuatro pequeñas ventas anteriores de acciones ordinarias por parte de Robert Werner por un total de 1,492 acciones entre el 21/05/2025 y el 04/08/2025, con los ingresos brutos informados para cada venta. El aviso incluye la certificación estándar de que el firmante no conoce información adversa material no divulgada.

Twist Bioscience(TWST)의 Form 144 통지는 내부자가 보통주를 매도하는 신고서를 나타냅니다. 신고인은 NASDAQ에서 Fidelity Brokerage Services를 통해 238주를 매도할 예정이며, 총 시가 가치는 $6,179.48이고 대략적인 매도 예정일은 2025-08-21입니다. 해당 주식은 2025-08-20에 제한주(리스트릭티드 스톡) 베스팅을 통해 보상으로 취득되었습니다. 신고서에는 또한 Robert Werner가 2025-05-21부터 2025-08-04 사이에 총 1,492주를 소액으로 매도한 네 건의 이전 거래가 기재되어 있으며, 각 거래의 총수익이 보고되어 있습니다. 통지에는 서명자가 공개되지 않은 중요한 불리한 정보를 알고 있지 않다는 표준 확인 문구가 포함되어 있습니다.

Avis Formulaire 144 de Twist Bioscience (TWST) indique un dépôt de vente par un initié concernant des actions ordinaires. Le déclarant prévoit de vendre 238 actions via Fidelity Brokerage Services sur le NASDAQ, pour une valeur de marché totale de 6 179,48 $ et une date de vente approximative au 21/08/2025. Les actions ont été acquises le 20/08/2025 lors de la levée de restrictions d'actions restreintes et ont été reçues en tant que rémunération. Le dépôt mentionne également quatre petites ventes antérieures d'actions ordinaires par Robert Werner totalisant 1 492 actions entre le 21/05/2025 et le 04/08/2025, avec les produits bruts indiqués pour chaque vente. L'avis inclut la certification standard selon laquelle le signataire n'est pas au courant d'informations défavorables importantes non divulguées.

Form 144-Mitteilung von Twist Bioscience (TWST) weist auf eine Insider-Verkaufsanzeige für Stammaktien hin. Der Einreicher plant, 238 Aktien über Fidelity Brokerage Services an der NASDAQ zu verkaufen, mit einem Gesamtmarktwert von $6.179,48 und einem ungefähr geplanten Verkaufsdatum am 21.08.2025. Die Aktien wurden am 20.08.2025 durch Vesting von eingeschränkten Aktien erworben und als Vergütung erhalten. Die Meldung listet außerdem vier frühere kleinere Verkäufe von Stammaktien durch Robert Werner mit insgesamt 1.492 Aktien zwischen dem 21.05.2025 und dem 04.08.2025 auf, wobei die Bruttoerlöse für jeden Verkauf angegeben sind. Die Mitteilung enthält die übliche Bestätigung, dass der Unterzeichner keine nicht offengelegten, wesentlichen nachteiligen Informationen kennt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 filed for 08/21/2025 disclose?

It discloses a proposed sale of 238 common shares valued at $6,179.48 through Fidelity on NASDAQ, acquired 08/20/2025 via restricted stock vesting.

Who acquired the securities being sold according to the filing?

The securities were acquired from the issuer on 08/20/2025 as restricted stock vesting and were paid as compensation.

Has the seller made other sales of TWST stock recently?

Yes. The filing lists four prior sales by Robert Werner on 05/21/2025, 05/23/2025, 06/06/2025, and 08/04/2025 totaling 1,492 shares with reported gross proceeds per trade.

What broker will execute the planned sale in the Form 144?

Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI 02917) is named as the broker for the 238-share sale.

Does the filing indicate any undisclosed material information about the company?

No. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.60B
59.18M
1.88%
116.82%
17.29%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO